Journals / ADO Klinik Bilimler Dergisi / 2012 / Cilt: 5 - Sayı: 4

Bisphosphonates And New Treatment Approachs of Bisphosphonate Related Osteonecrosis of the Jaws İn Oral And Maxillofacial Surgery

Oral Ve Maksillofasial Cerrahide Bifosfonatlar Ve Bifosfonatla İlişkili Çene Osteonekrozu Tedavisinde Yeni Yaklaşımlar

Pages
1052–1062
Publication Date
2012-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The purpose of this review is giving information about the mechanism of action of bisphosphonates, their use and the new treatment approachs of bisphosphonate-related osteonecrosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The use of biphosphonates for the treatment of osteoporosis and malignant tumors has caused an increase in the incident of osteonecrosis of the jaw recently.
📊
Key Findings & Data:Therefore, oral maxillofacial surgeons have begun to investigate the relationship of between bisphosphonates and jaw osteonecrosis, treatment of jaw osteonecrosis.
💡
Conclusion & Impact:The purpose of this review is giving information about the mechanism of action of bisphosphonates, their use and the new treatment approachs of bisphosphonate-related osteonecrosis
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Bisphosphonate · Jaw osteonecrosis · Bifosfonat

Abstract

The use of biphosphonates for the treatment of osteoporosis and malignant tumors has caused an increase in the incident of osteonecrosis of the jaw recently. Therefore, oral maxillofacial surgeons have begun to investigate the relationship of between bisphosphonates and jaw osteonecrosis, treatment of jaw osteonecrosis. The purpose of this review is giving information about the mechanism of action of bisphosphonates, their use and the new treatment approachs of bisphosphonate-related osteonecrosis

Özet

Bifosfonatların; osteoporoz ve malign tümör tedavisinde kullanılmasıyla, günümüzde çene osteonekrozunun görülme sıklığını artmıştır. Bu nedenle, oral maksillofasial cerrahlar bifosfonatlar ile çene osteonekrozunun ilişkisini ve çene osteonekrozunun tedavisini araştırmaya başlamışlardır. Bu derlemede bifosfonatların etki mekanizması, kullanım alanları ve bifosfonata bağlı oluşan osteonekrozların tedavisinde uygulanan yeni tedavi protokolleri hakkında bilgi verilmesi amaçlanmıştır

🔖

Cite This Article

KARAÇELEBİ, E., ÖZTÜRK, M. (2012). Bisphosphonates And New Treatment Approachs of Bisphosphonate Related Osteonecrosis of the Jaws İn Oral And Maxillofacial Surgery. ADO Klinik Bilimler Dergisi, Cilt: 5 - Sayı: 4, 1052–1062. https://ajindex.com/articles/728872

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Soydan S., Veziroglu F., Araz K. Bifosfonata Bağlı Olarak Çene Kemiklerinde Gelişen Osteo- nekrozun Patogenezi ve Tedavisi. Hacettepe Diş Hekimliği Fakültesi Dergisi. 33:61-68, 2009. Fleisch H. Development of bisphosphonates. Bre- ast Cancer Res. 4:30-34, 2002
  2. Yıldız N., Alpay H. Use of Biphosphonates in Pe- diatric Nephrology Biphosphonates in Pediatric. Turkish Nephrology, Dialysis and Transplantation Journal. 20:132-141, 2011
  3. Ruggiero S., Dodson TB., Assael LA., Landesberg R., Marx RE., Mehrotra B. American Association of Oral and Maxillofacial Surgeons Position Pa- per on Bisphosphonate-Related Osteonecrosis of the Jaw. Aust. Endod. J. 35:119-130, 2009
  4. Zafersoy Z., Kahraman S. Kemik Metastazı Yap- mış Prostat Kanseri Tedavisinde Kullanılan Bifos- fonata Bağlı Olarak Çene Kemiklerinde Gelişen Osteonekroz: Vaka Raporu Ve Literatür Derleme- si. Atatürk Üniv. Diş. Hek. Fak. Derg. 18:105- 110, 2008.
  5. Fournier P., Boissier S., Filleur S., Guglielmi J., Cabon F., Colombel M., Clézardin P. Bisp- hosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res. 62:6538-6544, 2002.
  6. Giuliani N., Pedrazzoni M., Passeri G., Giraso- le G. Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand. J. Rheumatol. 27:38-41,1998. Watts N. Treatment of osteoporosis with bisp- hosphonates. Endocrinol. Metab. Clin. North Am. 27:419-439, 1998. Tuncer B. Bifosfonatlar ve Diş Hekimliği. SÜ Diş- hek. Fak. Derg. 16:57-60, 2007. Woo SB., et al. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann. Intern. Med. 144:753–761, 2006. Scoletta M.,Arduino PG., Dalmasso P., Broccolet- ti R., Mozzati M. Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study. Oral Surg. Oral Med. Oral Radiol. Endod. 110:46-53, 2010. Ruggiero SL.,Mehrotra B., Rosenberg TJ., Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J. Oral Maxillofac. Surg. 62:527-534, 2004. Almăşan HA., Băciuţ M., Rotaru H., Bran S, Almăşan O.C., Băciuţ G. Osteonecrosis of the jaws asso- ciated with the use of bisphosphonates Discus- sion over 52 cases. Rom. J. Morphol. Embryol. 52:1233–1241, 2011.
  7. Tanvetyanon T., Stiff PJ. Management of the ad- verse effects associated with intravenous bisp- hosphonate. Annals of Oncology. 17: 897–907, 2006.
  8. Rizzoli R., Burlet N., Cahall D, Delmas PD., Erik- sen EF., Fels